tiprankstipranks
Bionexus Gene Lab Corporation (BGLC)
:BGLC
US Market

BioNexus Gene Lab Corp (BGLC) Financial Statements

Compare
64 Followers

BioNexus Gene Lab Corp Financial Overview

BioNexus Gene Lab Corp's market cap is currently $5.88M. The company's EPS TTM is $-0.052; its P/E ratio is ―; BioNexus Gene Lab Corp is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 9.77M$ 10.93M$ 13.36M$ 11.39M$ 126.95K
Gross Profit$ 1.33M$ 1.26M$ 2.19M$ 1.72M$ 55.89K
Operating Income$ -2.59M$ -291.18K$ 1.06M$ 1.27M$ -275.70K
EBITDA$ -2.49M$ -185.76K$ 1.16M$ 1.38M$ -222.37K
Net Income$ -2.63M$ -355.97K$ 751.57K$ 1.09M$ -246.47K
Balance Sheet
Cash & Short-Term Investments$ 5.93M$ 2.12M$ 2.12M$ 2.79M$ 859.08K
Total Assets$ 11.40M$ 8.74M$ 9.57M$ 10.12M$ 1.23M
Total Debt$ 133.40K$ 56.77K$ 76.95K$ 123.42K$ 89.44K
Net Debt$ -5.80M$ -2.06M$ -2.05M$ -2.66M$ -769.64K
Total Liabilities$ 1.74M$ 2.08M$ 2.39M$ 3.45M$ 108.87K
Stockholders' Equity$ 9.66M$ 6.67M$ 7.18M$ 6.66M$ 1.12M
Cash Flow
Free Cash Flow$ -1.45M$ 489.86K$ 6.00K$ 131.06K$ -230.09K
Operating Cash Flow$ -1.30M$ 544.03K$ 9.16K$ 552.68K$ -217.27K
Investing Cash Flow$ -382.58K$ -450.50K$ -490.57K$ 1.32M$ -12.82K
Financing Cash Flow$ 5.75M$ 115.96K$ -28.22K$ -4.95K$ -180.81K
Currency in USD

BioNexus Gene Lab Corp Earnings and Revenue History

BioNexus Gene Lab Corp Debt to Assets

BioNexus Gene Lab Corp Cash Flow

BioNexus Gene Lab Corp Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis